Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Con Kelleher

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
BJU International|July 6, 2013
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladderDavid Ginsberg, Tim Schneider, Con Kelleher, et al.
European Urology|April 28, 2018
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysisCon Kelleher, Zalmai Hakimi, Richard Zur, et al.
Gastroenterology|February 24, 2004
Symptom severity and QOL scales for urinary incontinenceMichelle J Naughton, Jenny Donovan, Xavier Badia, et al.
BJU International|April 5, 2007
Overactive bladder syndrome in older peopleAdrian S Wagg, Linda Cardozo, Christopher Chapple, et al.
Neurourology and Urodynamics|January 24, 2018
Development of an overactive bladder assessment tool (BAT): A potential improvement to the standard bladder diaryCon Kelleher, Christopher Chapple, Nathan Johnson, et al.
European Urology|March 12, 2014
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony)Paul Abrams, Con Kelleher, David Staskin, et al.
European Urology|October 20, 2006
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC studyDebra E Irwin, Ian Milsom, Steinar Hunskaar, et al.
European Urology Focus|January 16, 2021
Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB OutcomesChristopher Chapple, Con Kelleher, Emad Siddiqui, et al.
BJU International|July 12, 2008
A review of adherence to drug therapy in patients with overactive bladderRamandeep K Basra, Adrian Wagg, Christopher Chapple, et al.
Neurourology and Urodynamics|July 14, 2017
Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patientsDudley Robinson, Con Kelleher, David Staskin, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
BJU International|July 6, 2013
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladderDavid Ginsberg, Tim Schneider, Con Kelleher, et al.
European Urology|April 28, 2018
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysisCon Kelleher, Zalmai Hakimi, Richard Zur, et al.
Gastroenterology|February 24, 2004
Symptom severity and QOL scales for urinary incontinenceMichelle J Naughton, Jenny Donovan, Xavier Badia, et al.
BJU International|April 5, 2007
Overactive bladder syndrome in older peopleAdrian S Wagg, Linda Cardozo, Christopher Chapple, et al.
Neurourology and Urodynamics|January 24, 2018
Development of an overactive bladder assessment tool (BAT): A potential improvement to the standard bladder diaryCon Kelleher, Christopher Chapple, Nathan Johnson, et al.
European Urology|March 12, 2014
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony)Paul Abrams, Con Kelleher, David Staskin, et al.
European Urology|October 20, 2006
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC studyDebra E Irwin, Ian Milsom, Steinar Hunskaar, et al.
European Urology Focus|January 16, 2021
Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB OutcomesChristopher Chapple, Con Kelleher, Emad Siddiqui, et al.
BJU International|July 12, 2008
A review of adherence to drug therapy in patients with overactive bladderRamandeep K Basra, Adrian Wagg, Christopher Chapple, et al.
Neurourology and Urodynamics|July 14, 2017
Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patientsDudley Robinson, Con Kelleher, David Staskin, et al.
Pageof 4